FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to medicine and aims at HIV-infection treatment. That is ensured by introduction of a T-cell depletor which effectively disintegrates all T-cells of the patient. Said depletor is a CD52 monoclonal antibody Alemtuzumab.
EFFECT: invention allows suppressing the immune system by the controlled method.
8 cl, 2 ex, 2 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOSITION FOR PREVENTING AND TREATING VIRAL INFECTIONS | 2009 |
|
RU2505306C2 |
| QUINOLINE DERIVATIVES FOR USE IN TREATING OR PREVENTING VIRAL INFECTION | 2016 |
|
RU2723016C2 |
| INGENOL DERIVATIVES FOR REACTIVATION OF LATENT HIV VIRUS | 2013 |
|
RU2609512C2 |
| CCR5 EXPRESSION SUPRESSION COMPOSITIONS AND METHODS OF APPLICATION THEREOF | 2004 |
|
RU2353357C2 |
| METHODS OF TREATING HIV-1 INFECTION | 2020 |
|
RU2827716C1 |
| METHOD FOR TREATING HIV-INFECTED PATIENTS | 2003 |
|
RU2237484C1 |
| CCR5 ANTAGONIST FOR ENHANCING IMMUNORESTORATIVE THERAPY AND TREATMENT OF OPPORTUNISTIC INFECTION IN PATIENTS WITH HIV | 2007 |
|
RU2420284C2 |
| METHOD OF INHIBITING HIV REPLICATION IN CELLS OF MAMMALS AND HUMANS | 2011 |
|
RU2593948C2 |
| IMMUNOGENIC COMPOSITION AND METHOD OF ELABORATION OF VACCINE BASED ON PSORALEN-INACTIVATED HIV | 2004 |
|
RU2401665C2 |
| STRAIN HOMINIS IMMUNODEFICITI VIRUS (HIV-1) HIV-1 /RUSSIA/(316RU) FOR PREPARING DIAGNOSTIC, PROPHYLACTIC PREPARATIONS AND FOR ASSESSING ANTIVIRAL ACTIVITY OF VARIOUS COMPOUNDS | 2011 |
|
RU2457244C1 |
